C88.91

Clinical Causes: Genetic mutations affecting lymphoid or plasma cells Exposure to radiation or certain chemicals Chronic infections or immune system dysregulation History of other lymphoid or hematologic cancers

Key Symptoms: Often asymptomatic during remission Possible lingering fatigue or weakness Swollen lymph nodes or spleen in some cases Unusual infections due to immune system impairment Unexplained weight loss or night sweats in active disease phases

Diagnosis Path: Diagnosis of a malignant immunoproliferative disease involves a combination of clinical evaluation, laboratory tests, and imaging studies. During active phases, issues such as abnormal blood cell counts, presence of abnormal lymphoid cells in biopsies, and imaging that shows enlarged lymph nodes or organs are common. When a patient is in remission, tissue biopsies or blood tests may show no evidence of active disease, confirming the remission status. Monitoring typically continues to detect any signs of disease recurrence or progression.

Treatment Protocols: While in remission, the focus is on maintaining health and monitoring for potential relapse. Treatments during active disease stages may include chemotherapy, targeted therapy, immunotherapy, or stem cell transplants. In remission, treatment may involve supportive care and regular check-ups. The goal is to ensure the disease remains controlled and to promptly address any signs of return. Patients are advised to follow their healthcare provider’s recommendations closely, including routine blood work and imaging tests.